EVK-001

After gaining a sufficient understanding of the importance of clinical Phase I and Phase II trials, it's time to move on to the importance of Phase III trials. To recap, a Phase I trial consists of a pharmaceutical company testing a new drug or treatment in a small group of people to evaluate its...

Evoke Pharma Inc (NASDAQ: EVOK), a specialty pharmaceutical company that focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases, issued a blow to investors Monday morning. Evoke said top-line results from a Phase 3 clinical trial of EVK-001 in female patients...

In an exclusive interview with Benzinga, Evoke Pharma (NASDAQ: EVOK) CEO Dave Gonyer discussed the company’s opportunities. Evoke is currently focused on its drug EVK-001. EVK-001 is a nasal spray to treat diabetic gastroparesis. Gonyer began by discussing the drug's potential market....